NATAP/CROI 2008 Report-Metabolics/Renal/Bone/Aging

[Guest guest]

In a message dated 4/3/08 2:59:06 PM, JuLev writes:

NATAP REPORTS

Metabolic Complications: A CROI 2008 Summary Written by Alain Wohl, MD - The University of North Carolina - (04/03/08)

Co-Morbidities

 

Risk for Cardiovascular Disease and Regional Adipose Tissue Depots Among HIV-infected Men and Women in the Study of Fat Redistribution and Metabolic Changes in HIV Infection (FRAM) (03/12/08)

 

Inflammatory Markers Correlate with Carotid Intima-Media Thickness and Endothelial Activation in HIV-infected Patients (03/12/08)

 

MELD is the Best Predictor of Pre-transplant Mortality in HIV-infected Liver Transplant Candidates???? NO - (03/07/08)

 

Prevalence and Risk Factors in HIV-infected Persons for Echocardiographic Abnormalities in the Era of Modern HAART - (03/05/08)

 

Role of Antiretroviral Therapy, Viral Replication, and HIV Infection in Atherosclerosis - (03/07/08)

 

Lipoatrophy and lipohypertrophy are independently associated with hypertension (FRAM): the effect of lipoatrophy but not lipohypertrophy on hypertension is independent of obesity - (03/07/08)

 

Evaluation of Pregnancy PBMC and Placental MtDNA in HIV-infected, HAART-treated Women, Compared to HIV-uninfected Women - (03/07/08)

 

Diastolic Dysfunction is Common in Asymptomatic HIV Patients - (03/07/08)

 

Cardiovascular Risk Markers Greatly Inflate Death Risk in People With HIV; interruptions increase risk - Written by Mark Mascolini (02/12/08)

 

Lower Noninfectious Disease Rates With HAART in All CD4 Brackets - Written by Mark Mascolini (02/19/08)

 

Fat Changes Boost Heart Disease and Diabetes Risk in HIV-Infected Men - Written by Mark Mascolini (02/19/08)

 

Resuming Therapy Can't Reverse Progression Risk With Off-and-On Therapy - Written by Mark Mascolini (02/04/08)

 

Insufficient Virus Suppression during HAART Is a Strong Predictor for the Development of AIDS-related Lymphoma: German CLINSURV Cohort - (02/25/08)

 

Immunodeficiency and Risk of AIDS-defining and Non-AIDS-defining Cancers: ANRS CO3 Aquitaine Cohort, 1998 to 2006 - (02/25/08)

 

Incidence Anal Squamous Intraepithelial Lesions (SIL) and Predictors of in the SUN Study after One Year of Follow-up - (02/22/08)

 

Renal Report by Wyatt/Klotman Mt Sinai (02/12/08)

 

Kidney - Proteinuria, Glomerular Filtration Rate Reductions, and Associated Factors among HIV-Infected and Uninfected Men in the Multicenter AIDS Cohort Study (MACS) (02/14/08)

 

HIV-Specific Risk Factors for Nonalcoholic Fatty Liver Still Elusive - Written by Mark Mascolini (03/04/08)

 

Racial Disparity in Kidney Disease At Hopkins: Sharp Racial Disparities in Kidney Trouble and End-Stage Disease in HIV+ Cohort - Written by Mark Mascolini - (02/20/08)

Endothelial Activation Markers Are Linked to HIV Status and Are Independent of ART and Lipoatrophy - (03/05/08)

Do Lipid Signals Favor Maraviroc Over Efavirenz in Untreated People? - Written by Mark - (02/26/08)

 

Fasted Lipid Changes after Administration of Maraviroc or Efavirenz in Combination with Zidovudine and Lamivudine (Combivir) for 48 Weeks to Treatment-naive HIV-infected Patients (02/05/08)

Abacavir & MI (myocardial infarction) Risk in D.A.D Study - Written by Mark Mascolini (02/05/08)

Multicenter, Retrospective Study of Incidence and Predictors of Adverse Events Associated With Nevirapine Use in a Cohort of Pregnant and Nonpregnant Women Treated at 3 Urban HIV Clinics in the United States - (02/20/08)

Metabolics, Bone Disease

 

Metabolic Complications: A CROI 2008 Summary - Written by Alain Wohl, MD - The University of North Carolina - (04/03/08)

 

Bone Disease Is Increased in HIV; Cancer Risk Increases with Age & Immune Deficiency - (03/25/08)

 

Review of Bone Posters at CROI 2008 - Written by Overton, M.D. - (03/10/08)

 

HIV and Aging at CROI 2008 - (03/10/08)

 

Influence of NRTI Choice and Efavirenz Versus Lopinavir Treatment Options on Lipoatrophy-Associated Adipose Tissue Toxicity: A Longitudinal Study - (03/07/08)

 

Endothelial Activation Markers Are Linked to HIV Status and Are Independent of ART and Lipoatrophy - (03/05/08)

 

Even Totally Controlled HIV Linked to Atherosclerosis Risk - Written by Mark Mascolini (02/06/08)

 

Bone Mineral Density (BMD) 96 Weeks after Antiretroviral Therapy (ART) Initiation: A Randomized Trial Comparing Efavirenz (EFV)-Based Therapy to a Lopinavir/ritonavir (LPV/r)-Containing Regimen with Simplification to LPV/r Monotherapy - (02/27/08)

 

Risk Factors for Reduced Bone Mineral Density In HIV-Infected Individuals In The Modern HAART Era - (02/22/08)

 

Bone Metabolism in HIV: CROI 2008 Update - written by Todd T. Brown, MD, PhD - (02/21/08)

 

HIV & ART Led to Bone Loss (02/19/08)

 

Worse HIV Control--Not Antiretrovirals--Linked to Low Bone Density in Vancouver; ART risk factor in 2nd study - Written by Mark Mascolini (02/19/08)

 

Effects of Diet and Exercise and/or Rosiglitazone on Body Composition and Lipids including Oxidized LDL in HIV+ and HIV- Men and Women - (02/26/08)

 

Metabolic Syndrome Does Not Up Death Risk in HIV Cohort--But Bad Lipids Do - Written by Mark Mascolini (02/14/08)

 

Clinical Associations of Extremity Fat Loss from ACTG 5142: A Prospective, Randomized, Phase III Trial of NRTI-, PI-, and NNRTI-sparing Regimens for Antiretroviral Therapy (ART) of Naive, HIV-1 infected Subjects (02/14/08)

 

Switching from Combivir [CBV] (AZT/3TC) to Truvada [TVD] (TDF/FTC) Preserves Limb Fat: Results of a DEXA Sub-Study of a 48 Week Randomised Study - (02/19/08)

 

Sustained Treatment With Tesamorelin Needed to Keep Belly Fat Off - written by Mark Mascolini - (02/26/08)

 

Limb Fat Loss Must Reach 30% Before Patients and Physicians See It - Written By Mark Mascolini - (02/26/08)

 

Data on 52-Week Safety and Efficacy of Tesamorelin, a Growth Hormone-releasing Factor Analogue, in HIV-infected Patients with Abdominal Fat Accumulation - (02/22/08)

 

Pharmacology

 

Clinical Pharmacology at CROI 2008: Drug Delivery and Disposition, Drug Interactions, Pharmacogenetics and Applications to Patient Care - written by V. Fletcher, Pharm.D.(02/20/08)**************Planning your summer road trip? Check out AOL Travel Guides. (http://travel.aol.com/travel-guide/united-states?ncid=aoltrv00030000000016)